| Mr Alan M Polniak, | |
|
3010 Skylark Dr, Columbia, MO 65203-3014 | |
| (573) 442-5670 | |
| Not Available |
| Full Name | Mr Alan M Polniak |
|---|---|
| Gender | Male |
| Speciality | Audiologist |
| Location | 3010 Skylark Dr, Columbia, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306886437 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 01916 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Alan M Polniak, 3010 Skylark Dr, Columbia, MO 65203-3014 Ph: (573) 814-6350 | Mr Alan M Polniak, 3010 Skylark Dr, Columbia, MO 65203-3014 Ph: (573) 442-5670 |
News Archive
Doctors at the University of Rochester Medical Center are the first in the nation to implant an investigational medical device that lowers blood pressure by activating the body's natural blood pressure regulation systems.
Gilead Sciences, Inc. has announced receipt of a Paragraph IV Certification Notice Letter advising that Teva Pharmaceuticals submitted an Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration (FDA) requesting permission to manufacture and market a generic version of Atripla (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg). Atripla is currently sold in the United States through a joint venture between Bristol-Myers Squibb and Gilead.
"Alzheimer's disease is a scourge afflicting Americans in every state and community. According to a new report, it affects 35 million people around the world - and that number is expected to nearly double in 20 years, to more than 65 million in 2030.
Aalto University neuroscientists, in collaboration with researchers at Helsinki University Hospital and Harvard Medical School, have found a novel connection between the size of the choroid plexus in the brain and complex regional pain syndrome (CRPS).
XBiotech is announcing that results from its Phase I/II oncology study conducted at MD Anderson Cancer Center in Houston, TX were published today in Lancet Oncology. The featured article describes the outcome in 52 advanced cancer patients treated with Xilonix™, XBiotech's novel, non-cytotoxic, anti-tumor therapy.
› Verified 6 days ago
Dr. Amber N Cichon, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 525 N Keene St Ste 201, Columbia, MO 65201 Phone: 573-882-4327 | |
Christina A Gash, M.S., CCC-A, FAAA Audiologist Medicare: Not Enrolled in Medicare Practice Location: 800 Hospital Dr, Hstmvh, S/c Audio, Columbia, MO 65201 Phone: 573-814-6350 Fax: 573-814-6328 | |
Tessa Thao Vi Nguyen, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 525 N Keene St, Columbia, MO 65201 Phone: 573-882-4327 Fax: 573-884-3316 | |
Karen E. Bauer, Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1213 Subella Dr, Columbia, MO 65203 Phone: 573-445-3275 | |
Amanda Elizabeth Mccarthy, Audiologist Medicare: Medicare Enrolled Practice Location: 525 N Keene St Ste 201, Columbia, MO 65201 Phone: 573-882-4327 Fax: 573-884-3316 | |
Patricia A. Beringer, Audiologist Medicare: Medicare Enrolled Practice Location: 525 N Keene St Ste 201, Columbia, MO 65201 Phone: 573-882-4327 Fax: 573-884-3316 | |
Dr. Haley Brantley, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 525 N Keene St, Columbia, MO 65201 Phone: 573-882-4327 Fax: 573-884-3316 |